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During their development, T cells are rescued from
apoptotic cell death to follow distinct lineage fates.
Recent data concerned with the role of the Notch
transmembrane receptor in these events are interpreted
to show that Notch promotes survival, but contrary to
earlier reports has no function in lineage commitment.
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As lymphocytes develop from pluripotent stem cells, they
rearrange their antigen receptor genes, which are present
in pieces in the germ-line genome. These gene segments
must be rearranged to produce functional receptors in
order for a lymphocyte to survive and mature. Indeed
several ‘checkpoints’ have been identified at which devel-
oping T and B lymphocytes have to make a particular type
of receptor in order to proceed to the next developmental
stage. In the case of T cells, not only whether they will
survive but also which particular lineage they will follow is
determined at these checkpoints [1]. 
The molecular mechanisms underlying these processes
are not known, and may depend entirely or in part on the
particular receptor expressed. T-cell development can also
be influenced by the evolutionarily conserved transmem-
brane receptor Notch. The indications of this [2,3] sug-
gested that Notch affects T-cell lineage commitment,
analogous to its impact on lineage decisions in the fruitfly
Drosophila [4]. But a new paper [5] claims that Notch has
an anti-apoptotic activity in T-cell development, rather
than a function in lineage commitment.
There are two checkpoints during T-cell development at
which cells are rescued from cell death and enter distinct
lineages (Figure 1). The first occurs as T-cell receptor β, γ
and δ genes rearrange. If a cell makes productive γ and δ
rearrangements, it can express the heterodimeric γδ recep-
tor; if it makes a productive β rearrangement, it can make
the pre-T-cell receptor that consists of the β chain and the
pre-T-cell receptor α protein, which is encoded by a non-
rearranging gene [6]. Cells that can produce neither the γδ
receptor nor the pre-T-cell receptor will die at this stage of
development. Cells that express the γδ or the pre-T-cell
receptor can enter the γδ or αβ T-cell lineage. These lin-
eages have distinct properties, which means they can be
defined independently of the particular antigen receptor
expressed, and it is not yet clear to what extent expression
of either the γδ or pre-T-cell receptor determines lineage
commitment, or how this is effected at a molecular level.
Cells that enter the αβ lineage pass through a second
checkpoint as they rearrange and express their α chain
genes. In αβ lineage cells, the pre-T-cell receptor rescues
cells from death, terminates further rearrangement at the
β, γ and δ loci and induces a strong wave of proliferation,
followed eventually by rearrangements at the α chain
locus and expression of CD4 and CD8 ‘coreceptors’ [7].
These so-called CD4+CD8+ cells, some of which express
an αβ T-cell receptor, cease dividing and are programmed
to die after three to four days unless their antigen receptor
and CD4 or CD8 coreceptor together bind to thymic
major histocompatibility complex (MHC) molecules.
While the αβ receptor binds to peptides presented by
either class I or class II MHC molecules, CD4 binds only
to class II and CD8 only to class I MHC molecules.
Appropriate binding of the αβ receptor and coreceptors to
the same MHC molecule results in rescue of the cells
from apoptotic cell death, and the rescued cells differenti-
ate into either CD4+CD8– cells or CD4–CD8+ cells
(Figure 1), depending on whether their αβ T-cell receptor
is specific for class II or class I MHC presented peptides
[8]. The CD4 and the CD8 lineages of mature T cells
have distinct properties, and again the molecular mecha-
nisms of lineage commitment may depend entirely or in
part on the specificity of the receptor.
The first reports analysing the impact of Notch on T-cell
development postulated a role for Notch in lineage deci-
sion at both checkpoints [2,3]. These experiments built
upon the previous analysis of Notch function in the fruitfly
Drosophila, where Notch is believed to be involved in
lineage decisions of ectodermal cells [4]. Neighbouring
cells with slightly different levels of Notch and Notch
ligands on the cell surface are thought to influence each
other by lateral signalling, such that the difference
becomes exaggerated and one cell expresses high levels of
Notch while the other cell does not. This can result in dis-
tinct lineage commitment in that cells expressing high
levels of Notch assume one developmental fate, while the
cells expressing low levels assume another, as seen in the
experiments on Drosophila ectodermal cells. In mosaic
fruitflies containing both Notch+/+ and Notch+/– ectodermal
cells, the latter regularly assumed the neural fate only,
while in Notch+/– fruitflies such cells contributed to both
epidermis and neurons [8]. At a molecular level, it is
known that the activation of Notch by various ligands
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results in cleavage of the receptor such that the intracellu-
lar domain — known as Notch IC — can act in the nucleus
and initiate signalling. Furthermore, Notch signalling can
enhance Notch expression, leading to positive feedback [9]. 
The experiments looking at the effect of Notch activity on
the first checkpoint in T-cell development used mice with
a chimaeric haemopoietic system populated by a mixture
of Notch+/– and Notch+/+ cells. An effect on lineage commit-
ment to either the γδ or αβ lineage was postulated,
because in these chimaeras the Notch+/– T cell precursors
appeared to contribute less to the αβ lineage than Notch+/+
precursors. Also, an activated Notch transgene was shown
to increase significantly the number of αβ lineage
CD4+CD8+ cells in mice that were deficient in the T-cell
receptor β locus and so could not make either the pre-T-
cell receptor or the αβ receptor. These experiments could
be interpreted as indicating that cells expressing high
levels of Notch assume the αβ lineage fate by lateral sig-
nalling mechanisms similar to those causing ectodermal
cells to assume an epidermal fate. The observed changes
caused by active Notch were, however, not independent
of receptor gene rearrangement, as Notch transgenic,
rearrangement-deficient Rag–/– mice did not show any
accumulation of αβ lineage cells [3].
At the second checkpoint in T-cell development, active
Notch caused an accumulation of CD4–CD8+ T cells,
even in mice deficient in MHC class I molecules, but not
in MHC-negative mice. This was interpreted to show that
at this point in development the CD8 lineage, which nor-
mally requires ligation of the receptor by class I MHC
molecules, was favoured by cells expressing active Notch.
Unlike normal CD8 cells, however, the cells rescued by
Notch were short-lived and could not be detected in sec-
ondary lymphoid tissue [2].
The interpretation of these results has now been
challenged by Deftos et al. [5]. They observed that the
intracellular form of Notch, Notch IC, mediates resistance
to corticosteroid-induced apoptosis, to which CD4+CD8+
thymocytes are particularly susceptible. Resistance to
apoptosis requires activation of the transcription factor
RBP/Su(H). Deftos et al. [5] also describe a Notch IC-
dependent increase in Notch expression that apparently is
dependent on activation of the Deltex gene as well as
upregulation of the anti-apoptotic gene bcl-2 in an AKR
thymoma. This cell line resembles CD4+CD8+ thymocytes
in its expression of the CD4 and CD8 coreceptors, and in
normally being susceptible to corticosteroid-induced apop-
tosis. Interestingly, CD4+CD8+ thymocytes undergoing
rescue from apoptosis through binding of their αβ receptor
to MHC molecules resemble Notch IC-expressing AKR
cells in becoming resistant to apoptosis and upregulating
bcl-2 expression. Further parallels are seen in that surface
levels of the αβ receptor on the AKR thymoma increased
in response to Notch IC, mimicking the increase in cell
surface αβ receptor expression when CD4+CD8+ thymo-
cytes bind an appropriate peptide–MHC ligand and are
rescued from cell death.
Because of these interesting parallels, Deftos et al. [5]
searched for signs of Notch and Deltex activity in various
Figure 1
Checkpoints in T-cell development. At the first checkpoint, T cells that
have undergone receptor gene rearrangement are rescued from
programmed cell death by production of either a γδ receptor or the pre-
T-cell receptor. At the second checkpoint, cells on the αβ lineage are
rescued from programmed cell death by binding of their αβ T-cell
receptor to thymic MHC molecules. Commitment to either the αβ or γδ
lineage takes place at the first checkpoint, and commitment to either the
CD4+CD8– or CD4–CD8+ lineage takes place at the second checkpoint.
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thymocyte subsets. Among thymocytes, Notch and Deltex
expression was evident in double-negative CD4–CD8–
thymocytes, and in single-positive mature CD4+CD8– and
CD4–CD8+ thymocytes, but not in CD4+CD8+ thymo-
cytes. Furthermore, CD4+CD8+ thymocytes from mice
carrying a transgene encoding a constitutively active form
of Notch were less susceptible to apoptosis. From these
observations, Deftos et al. [5] conclude that Notch is
involved in the generation of not only CD4–CD8+ but also
CD4+CD8– thymocytes (Figure 2).
There is relatively little to be concluded from these
observations on the first checkpoint in T-cell develop-
ment, as CD4–CD8– thymocytes consist of distinct subsets
of cells that may or may not have passed through this
checkpoint and they have yet to be analysed separately for
Notch and Deltex expression. With regard to the second
checkpoint, Deftos et al. [5] note that a class I MHC-inde-
pendent generation of short-lived CD4–CD8+ thymocytes
was not only observed in Notch transgenic mice [2] but also
in bcl-2 transgenic mice [10], suggesting that enhanced cell
survival could be solely responsible for the generation of
these peculiar CD4–CD8+ cells.
On the basis of these observations, Deftos et al. [5]
develop a scenario, which could account for some of the
earlier findings that suggested a possible role for Notch in
lineage commitment at the second checkpoint in T-cell
development. They argue that the quality of the inter-
action of the T-cell receptor with MHC molecules may be
responsible for lineage fate decision, in that the
CD4+CD8– lineage might require a stronger receptor
signal than the CD4–CD8+ lineage, whereas Notch is
postulated to be involved only with survival. According to
this view, the better survival of CD4+CD8+ thymocytes in
Notch transgenic mice somehow facilitates the relatively
weak signalling required for CD4–CD8+ cell development,
but has little influence on the generation of CD4+CD8–
cells which requires stronger signals. While these notions
clearly belong in the category of immuno-speculation, it
may be of interest to test them with further experiments.
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Expression of Deltex and Notch genes at
various stages of T-cell development. (See
text for details.)Checkpoint 2
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